Comunicados de prensa - Ypsomed

Ypsomed semi-annual results 2014/15: report and press release

30/10/2014 - 07:00 Press Releases Ypsomed Group

Burgdorf – Ypsomed is emphatically forging ahead on the path of continued growth.

Leer más... Ypsomed semi-annual results 2014/15: report and press release

Ypsomed and Terumo Corporation agree on collaboration

03/10/2014 - 07:00 Press Releases Ypsomed Group

Burgdorf – Terumo Corporation a Japanese global operating medical technology group plans to supplement its range of products and services towards the pharmaceutical industry and integrate its prefillable polymer syringe PLAJEX™ into Ypsomed's autoinjector YpsoMate®. The first pharma customer has already placed an order for this new offering, with further customers expected.

Leer más... Ypsomed and Terumo Corporation agree on collaboration

Ypsomed newly supplies AstraZeneca with the Bydureon Pen

19/09/2014 - 07:00 Press Releases Ypsomed Group

Burgdorf – Starting in the US from September 2014, the glucagon-like peptide-1 (GLP-1) receptor agonist exenatide will be administered with the dual-chamber injection system Bydureon Pen, based on Ypsomed's LyoTwist® platform.

Leer más... Ypsomed newly supplies AstraZeneca with the Bydureon Pen

Ypsomed increases dividends to shareholders by 50%

02/07/2014 - 07:00 Press Releases Ypsomed Group

Burgdorf – Annual general meeting of July 1, 2014.

Leer más... Ypsomed increases dividends to shareholders by 50%

Ypsomed strengthens sales in its business segments

24/06/2014 - 07:00 Press Releases Ypsomed Group

Burgdorf – Injection Systems and Diabetes Care to be managed separately.

Leer más... Ypsomed strengthens sales in its business segments